The Notch signaling pathway plays an important role in many cell-fate decisions during development. Here we investigate the regulation and function of the conserved gene XNAP, which is a member of the Delta-Notch synexpression group in Xenopus. XNAP encodes a small protein with two C-terminal tandem ankyrin repeats which is expressed in the neurectoderm and in the presomitic mesoderm in a pattern that resembles that of other component of the Notch pathway. When a myc-tag form of XNAP is overexpressed in Xenopus or Hela cells, XNAP protein is detected both in the nucleus and the cytoplasm. In embryos and in animal cap assays, XNAP expression is activated, perhaps directly, by the Notch pathway and this activation appears to be Su(H) dependent. Overexpression of XNAP in embryos decreases Notch signaling, which leads to an increase in the number of primary neurons that form within the domains of the neural plate where neurogenesis normally occurs. In culture Hela cells, XNAP overexpression interferes with ICD activation of a Notch regulated reporter gene. Together, these data indicate that XNAP is a novel target of the Notch pathway that may, in a feedback loop, modulate its activity. q
Introduction
The Notch signaling pathway is an evolutionarily highly conserved mechanism for cell-cell communication that is important for cellular differentiation in various developmental processes and that has been implicated in a number of diseases (Gridley, 1997; Artanavis-Tsakonas et al., 1999) . In Xenopus, during primary neurogenesis, Notch inhibits neuronal differentiation induced by proneural gene expression and directs cells to an undifferentiated or alternative fate (Chitnis et al., 1995; Cornell and Eisen, 2000) . Notch signaling has been also shown to play a key role in the segmentation of the paraxial mesoderm into somites (Jen et al., 1999) .
The large single-pass transmembrane Notch receptor undergoes a complicated set of processing events during intracellular trafficking and at the cell surface (for review, see Weinmaster, 2000) . During transport to the membrane, the Notch receptor is cleaved by a convertase of the furin family in the trans Golgi network, generating an extracellular and a transmembrane fragment that remain associated and are found at the surface as a heterodimeric receptor (Logeat et al., 1998) . Activation of the Notch receptor occurs by direct contact with membraneanchored ligands from the DSL family (Delta, Serrate, LAG2). Transmission of the signal from the activated Notch receptor requires two additional proteolytic events. The first one is mediated by a TACE related metalloprotease and occurs outside the transmembrane domain (Brou et al., 2000; . The second one is mediated by a presenilin-dependent, gamma secretase and occurs in the transmembrane segment (Struhl and Greenwald, 1998; De Strooper et al., 1999; Ye et al., 1999) . These sequential cleavages lead to the release of the intracellular domain of Notch, NotchICD, which translocates to the nucleus, where it can associate to the CSL family of DNA-binding proteins (CBF1 in mammals, Su(H) in Drosophila and Lag1 in C. elegans) (Jarriault et al., 1995) . These CSL proteins function as transcriptional repressors by recruitment of histone deacetylase corepressor complexes (Kao et al., 1998; Hsieh et al., 1999) . On binding to CSL proteins, Notch ICD abolishes repression by displacing the corepressor complex and by activating transcription through interaction with histone acetyltransferases (Kurooka and Honjo, 2000) . ICD binding to CSL also recruits other proteins such as SKIP and lag3/mastermind that appear to stabilize the complex and participate in transactivation (Zhou et al., 2000; Wu et al., 2000; Petcherski and Kimble, 2000) .
Genes such as the one within the Enhancer of split complex [E(spl)-C] in Drosophila or vertebrate homologs such as ESR1 in Xenopus (Wettstein et al., 1997) which encodes bHLH transcriptional repressor proteins are critical effectors which are up-regulated by Notch. However, there is also considerable evidence suggesting that Notch signaling occurs independently of this CSL pathway (Shawber et al., 1996; Matsuno et al., 1997; Zecchini et al., 1999; Nagel et al., 2000; Bush et al., 2001) .
Despite the importance of the Notch pathway during vertebrate development, until now only a limited number of target genes have been identified that mediate its diverse action during development. In this report, we present the characterization of a gene, XNAP, originally termed 5D9, that encodes a protein containing two repeated ankyrinmotifs, we had identified in a large scale expression screening in Xenopus (Gawantka et al., 1998) . This gene has a temporal and spatial expression profile very similar to that of other genes of the Notch pathway such as X-Delta-1 (Chitnis et al., 1995) , ESR4 and ESR5 (Jen et al., 1999) . We have therefore classified the XNAP gene in the DeltaNotchsynexpression group , which implies that it is likely to be involved in Notch signaling. Here we have investigated this possibility and provided experimental evidence for a role of this protein in the Notch signaling cascade. We show that the expression of the XNAP gene, which is highly conserved during evolution, is activated by the CSL-dependent Notch signaling pathway. We also show that overexpression of the XNAP gene in Xenopus embryos and cultured cells decreases Notch signaling. We conclude that XNAP is a novel target of the Notch pathway that modulates its activity.
Results
2.1. Structure of the XNAP gene and comparison with homologous sequence in rat, mouse and zebrafish The 1.2 kb cDNA 5D9 clone (renamed XNAP for Xenopus Notch activated protein) has been isolated in a random screen by in situ hybridization designed to identify novel developmentally regulated genes in Xenopusembryos (Gawantka et al., 1998) . The nucleotide sequence of the clone predicts a transcript with 5 0 (469 nucleotides) and 3 0 (426 nucleotides) -untranslated regions and an open reading frame encoding a protein with 114 amino-acid residues (Fig.  1 ). Sequence analysis revealed that the XNAP protein includes at its C-terminus two ankyrin repeats, a motif that mediates protein-protein interactions (Sedgwick and Smerdon, 1999) . BLAST searches of the Expressed Sequence Tag data base (dbEST) with the XNAP sequence N-terminal to the ankyrin repeats identified rat, zebrafish and mouse cDNA fragments encoding peptides with high homology to XNAP throughout the open reading frame. The most conserved part is the region corresponding to the first ankyrin repeat (Fig. 1 ).
Subcellular distribution of a myc-tagged version of the XNAP protein
As the XNAP protein sequence shows no obvious subcellular localization signals as analyzed using the protein motif search (PSORT) program, to study its subcellular distribution, we constructed a plasmid encoding a 6 £ myc-tagged version of the protein. MT-XNAP protein localization was first studied in transfected Hela cells. In the vast majority of the transfected cells, staining in both the nucleus and cytoplasm was observed ( Fig. 2A,B) . RNA encoding the MT-XNAP protein was also injected into the animal pole of all the blastomeres of four-cell stage embryos, and localization of the translated product was examined at gastrula stage by immunostaining using a myc epitope antibody. In all injected cells, MT-XNAP signals are detected homogeneously (Fig. 2C ). This uniform XNAP staining is clearly distinct from the one observed in myc-tagged XSIP1 injected embryos (Van Grunsven et al., 2000) , where the signal localizes to the nucleus (Fig. 2D ).
XNAP expression pattern during embryogenesis and in adult organs
RNAase protection analysis of RNA extracted from embryos at different stages of embryogenesis indicates that the XNAP gene is expressed at low level before the mid-blastula stage, that it is activated in gastrulating embryos and that it remains expressed during later embry- Fig. 1 . Schematic representation of the XNAP protein and amino-acid alignment of XNAP with homologous proteins predicted from ESTs in zebrafish, rat and mouse. Dots represent gaps introduced into the amino acid sequence in order to obtain optimal sequence homology. Identical amino-acids are represented by hyphens. The two ankyrin repeats are indicated and aligned above a consensus for the ANK domain where amino acids conserved in more than 50% are indicated in capital letters (l: I, L, V aliphatic; u, A,G,S tiny; c, D,E,H,K,R charged residues). GenBank Accession numbers: zebrafish, AI957892; rat, AW915629; and AA800680; mouse, BF123514). ogenesis (Fig. 3A) . By whole-mount in situ hybridization, uniform low level of XNAP expression is detected in the ectoderm of ten embryos (Fig. 3C) . During gastrula stages, XNAP expression starts to be detected in the paraxial presomitic mesoderm around the blastopore region (Fig. 3D) . At late gastrula stages, XNAP expression also appears in stripes in the posterior neural plate and in the anterior end of the prospective neural plate in a stripe of cells called the anterior neural ridge (ANR) (Fig. 3E) . In neurula embryos, high level of XNAP expression persists in the posterior mesoderm and in the stripes within the neural plate but low level of expression remains clearly detectable in between them. In the anterior part of the embryo, XNAP staining is also detectable in a more internal stripe of cells corresponding to sites of the ventral forebrain and midbrain where neurons first form and in the trigeminal placodes (Fig. 3F,G) . In late neurula embryos, XNAP expression is detected in the closing neural tube and in the presomitic mesoderm. The strongest staining in the presomitic mesoderm is observed in the most posterior portion called the tailbud region (Fig. 3J ). This XNAP early expression profile is very similar to that of other genes involved in Notch signaling such as that of the enhancer of split related gene ESR9 (originally named 8C9, Gawantka et al., 1998) and X-Delta-1 (Fig. 4H,I ). At later stages of development, expression of XNAP occurs in the tailbud region, the paraxial presomitic mesoderm, the eye, the otic vesicles and in branchial crest segments (Fig. 3K ). In the neural tube, expression of XNAP, like that of ESR9 and X-Delta-1, is only detected within the ventricular zone ( Fig. 3L-N) . Thus, during early embryogenesis, the XNAP expression profile is highly reminiscent of that of genes of the Notch pathway.
In adult organs, as judged by RNAase protection, XNAP is expressed at variable levels in the different organs tested, the highest level of expression being detected in lung, skin and spleen (Fig. 3B) .
XNAP expression is regulated by the Notch pathway via Su(H)
We next examined the regulation of XNAP expression in embryos or in animal cap assays. As XNAP expression appears in the neural plate embryo where neurogenesis occurs, we first tested whether its expression can be activated by proneural genes. Therefore, Xenopus embryos were injected at the two-cell stage with RNA encoding the proneural factor X-NGNR1 and then analyzed by whole-mount in situ hybridization for XNAP RNA expression. Fig. 4A shows that XNAPexpression is upregulated on the injected side of X-NGNR1 injected embryos (41/62 embryos). The increase of XNAP expression observed in these X-NGNR-1 injected embryos is however less dramatic than that observed for neuronal markers such as N-tubulin (data not shown). Embryos overexpressing Xash3, another proneural gene that is much less effective than X-NGNR-1 to push cells towards neuronal differentiation, also show increased XNAP expression on the injected side (12/18 embryos). The strongest expression induced by overexpression of these proneural genes is always observed in the neural plate, but weaker staining can also be observed outside the neural tissue ( As the data above have shown that XNAP expression is closely related to that of other genes of the Notch pathway and because the induction of XNAP by proneural genes may be indirect, via their ability to stimulate lateral inhibition via activation of X-Delta-1 (Chitnis et al., 1995) , we examined the role of the Notch pathway in the induction of XNAPexpression. To increase Notch signaling, embryos were injected with RNAs encoding just the intracellular domain of X-Notch1 (NotchICD) which functions as a constitutively active receptor or with an activated form of Su(H), Su(H)Ank (Wettstein et al., 1997) . To inhibit the Notch pathway, a truncated form of X-Delta-1 called X-Delta-1
Stu that acts as a dominant negative mutant was used (Chitnis et al., 1995) . Overexpression of both NotchICD and Su(H)Ank induces strong ectopic expression of XNAP (NotchICD: 16/16 embryos; Su(H)Ank: 10/11 embryos). Conversely, embryos coinjected with X-Delta-1
Stu and LacZ RNA show a reduction of XNAP expression in the X-gal stained areas (27/27 embryos) (Fig. 4A) .
The regulation of XNAP expression has been also analyzed in neuralized animal caps. RNAs were coinjected at the two cell-stage with or without RNA encoding the neural inducer noggin. At late blastula stage, the animal caps were removed and cultured to the equivalent of the neural plate stage, and then assayed by RNAase protection for the expression of XNAP. For comparison, we also assayed the expression of the E(spl) related gene ESR1, which is also regulated by the Notch pathway (Wettstein et al., 1997) . As shown in Fig. 4B , XNAP expression, similarly to that of ESR1, is induced by overexpression of Notch-ICD and Su(H)Ank. The level of XNAP induction obtained is much higher in neuralized versus non neuralized animal caps. Overexpression of a wild type or a dominant negative mutant form of the DNA-binding protein Su(H), called Su(H)DBM, has not such positive effect. Finally, we also observed that coinjection of Su(H)DBM markedly interferes with XNAP and ESR1 activation by Notch ICD and affects partially the induction of XNAP and ESR1 by X-NGNR-1 (Fig. 4C) . Together, these results indicate that XNAP regulation follows closely that of ESR1. XNAP induction by Notch appears to occur through a Su(H)-dependent pathway. Induction of XNAP by proneural genes appears to occur both in a in a Su(H) dependent and independent manner.
To determine whether XNAP regulation by Notch is likely to be direct or not, we used inducible forms of ICDNotch (hGR-ICD22) and of Su(H)Ank (hGR-Su(H)Ank) that have been generated by fusing on the ligand binding domain of the human glucocorticoid receptor (Wettstein et al., 1997) . Using both of these inducible constructs, we first measured in noggin-neuralized ectoderm the time course of XNAP induction compared to that of the E(spl) gene ESR1 which may be a direct target of Notch (Wettstein et al., 1997) . In both cases, XNAP expression, like that of ESR1, is activated after as little as 30 min of exposure to dexamethasone, the increase of XNAP expression being however much weaker and initially slower than that of ESR1 (Fig. 5A) . We next asked whether hGR-Su(H)Ank could induce XNAP expression in the presence of cycloheximide, a protein synthesis inhibitor (Cascio and Gurdon, 1987) . We decided to perform this experiment in non-neuralized animal caps because we were concerned that the cycloheximide treatment could interfere with the ability of noggin to neuralize ectoderm. Non-neuralized animal caps expressing hGR- Su(H)Ank were excised at blastula stage, incubated for 1 h in the presence of cycloheximide, exposed for 2.5 h to dexamethasone and then assayed for XNAP and ESR1expression. Control caps showed that this exposure to cycloheximide reduces protein synthesis about 4-5 fold as judged by measurement of the incorporation of [ 35 S] methionine (data not shown). Consistent with the results obtained in Fig. 4B , we observed in naÏve ectodermal cells a weak (less than 2 fold) but reproducible induction of XNAP by addition of dexamethasone. Preincubation of the caps by cycloheximide does not appear to reduce the level of XNAP induction. By comparison, XNAP expression in cycloheximide treated caps differ from that of ESR1, which is upregulated by cycloheximide treatment (Fig.  5B) . Together, these results indicate that XNAP, like ESR1, may be a direct target of the Notch pathway and that there are however differences in the way both genes are regulated.
Overexpression of XNAP in Xenopus embryos induces a neurogenic phenotype
To gain insight into the function of XNAP, we overexpressed it in Xenopus embryos by injecting unilaterally twocell stage embryos with RNA encoding XNAP together with LacZ RNA. Injected embryos were stopped at neurula stage and analyzed for alterations in neurogenesis, first using the N-tubulin neuronal marker (Chitnis et al., 1995) . Embryos injected with XNAP show an increase on the injected side in the number of N-tubulin positive cells, this increase being limited to the domains were primary neurons normally form. Embryos injected with RNA encoding the myc-tagged Fig. 4 . Dissected neuralized animal caps were either left untreated or exposed to dexamethasone for 30, 60, 120 or 180 min before harvesting. Note that both XNAP and ESR1 expression increases rapidly after the addition of Dexamethasone, the increase of XNAP expression, in contrast to that of ESR1, being however initially weak. Experiments with both constructs have been repeated at least three times. In all experiments, similar kinetic of XNAP and ESR1 induction have been observed. (B) Nonneuralized animal caps were (1) or were not (2) incubated in the presence of cycloheximide (CH) for 1 h and then dexamethasone was added (1) or not (2) for 2.5 h. Note that the degree of dexamethasone induction of XNAP, like that of ESR1, is similar in CH treated or untreated caps. Cycloheximide treatment induces higher ESR1 expression but does not increase the basal level of XNAP expression. This experiment has been repeated three times. In each experiment, similar results have been obtained. Numbers above the blots indicate XNAP RNA expression levels after normalization to FGRr; numbers below the blot indicate normalized ESR1 RNA expression levels.
form of XNAP show the same phenotype ( Fig. 6A and data not shown). Similar results were obtained by staining the embryos with the earlier neuronal gene X-MyT-1which codes for a zinc finger protein that might play a role in the escape of cells to lateral inhibition (Bellefroid et al., 1996) and the Xaml gene, which encodes a RUNT domain transcription factor specifically expressed in the Rohon-Beard sensory neurons (Tracey et al., 1998) (Fig. 6C-E) . This phenotype we observed by overexpression of XNAP is similar, although less dramatic, to the one obtained by attenuation of Notch signaling by overexpression of dominant negative versions of Su(H) and X-Delta-1 (Chitnis et al., 1995; Wettstein et al., 1997) (Fig. 6F) . To understand the basis of this phenotype, we next tested the effect of overexpression of XNAP on the expression of components of the Notch pathway. We observed that in a number of XNAP injected embryos fixed at late gastrula or early neurula stages, the level of X-Delta-1 expression was slightly increased on the injected side (25/73 embryos) (Fig.  6G,H) . Such an effect was not observed in LacZ alone injected embryos (data not shown). The early expression of the Notch target ESR1 and ESR10 (originally named 11A19, Gawantka et al., 1998 ) genes were in contrast decreased (ESR1: 42/68 embryos; ESR10: 29/38 embryos) (Fig. 6I,J) . As these phenotypes are consistent with a loss of Notch signaling, it is likely that the increase in the number of neurons that occurs in XNAP injected embryos may be due to the ability of XNAP to block lateral inhibition.
To further understand how XNAP overexpression increases primary neurogenesis, we constructed two myctagged deletion mutants. The first one, XNAP ank (amino acids 46-114), lacks the region N-terminal to the ankyrin repeats. The second one, XNAP Nterm (amino acids 1-56), lacks the two ankyrin repeats. Overexpression of the XNAP ank mutant, in contrast to full-length XNAP, decreases the number of N-tubulin positive cells. No such negative effect on N-tubulin expression was observed by overexpression of the XNAP Nterm mutant (Fig. 6B and Table 1 ). These results suggest that the ankyrin region is an important domain of the XNAP protein. The fact that overexpression of XNAP ank has an opposite effect on N-tubulin than wild type XNAP and that it thus appears to behave as a dominant negative mutant also suggest that the XNAP protein may be implicated in complex interactions with other cellular factors.
Inhibition of Notch signaling in transfected cells by overexpression of XNAP
The results above suggest that XNAP increases neurogenesis by inhibiting Notch. To further understand how XNAP inhibits Notch signaling, we next tested in cultured cells the ability of XNAP to modulate the activation by ICD of a reporter gene. The luciferase reporter gene used in this assay is under the control of 1.4 kb of the 5 0 flanking region of the mouse HRT1/Hey-1 gene. The promoter activity of this HRT1/Hey1 gene has been shown to be up-regulated by activated forms of mammalian Notch receptors via several Su(H) binding sites (Maier and Gessler, 2000; Nakagawa et al., 2000) . As shown in Fig. 7 , this promoter is also activated by Xenopus Notch about 2.5 fold in Hela cells. Co-transfection of ICD with increasing amount of a XNAP results in a graduate decrease of the luciferase activity while transfection of XNAP alone with the luciferase reporter has no effect on basal reporter transcription. Cotransfection of the two XNAP deletion mutants does not appear to affect significantly ICD activation of the reporter, except at the highest dose where they both also have a negative effect (data not show).
Discussion
3.1. The XNAP gene expression resembles that of other Notch pathway genes and is regulated by Notch XNAP is a novel gene highly conserved in vertebrates that encodes a protein which contains in its carboxy-terminal region two ankyrin motifs. Ankyrin motifs have been found in a large number of functionally unrelated proteins, including the Notch receptor, and are thought to play a role in protein-protein interactions (Sedgwick and Smerdon, 1999) . Experiments with a MT-tagged version of the XNAP protein showed no obvious subcellular localization. However, this observation must be interpreted with caution because it involves overexpression of the protein, which can obscure endogenous XNAP subcellular localization. Furthermore, 6 myc-tags can modify the properties of nuclear proteins (Ferreiro et al., 1998) . In addition, as has been shown for other component of the Notch pathway (Frise et al., 1996) , this subcellular localization may also depend on the availability of additional interacting cellular components.
XNAP is expressed in regions of the embryo where Notch signaling is active, i.e., in the neural plate during neurogenesis, in the ventricular zone of the neural tube and in the presomitic mesoderm and upregulation of Notch activity induces XNAP expression. Disruption of Notch signaling by overexpression of a dominant negative Su(H) mutant inhibits activation by Notch, suggesting that this activation is mediated by a pathway which involves Su(H). In addition, the results obtained with inducible forms of ICD and Su(H)Ank suggest that the regulation of XNAP may be direct. Although XNAP and ESR1 (Wettstein et al., 1997) appear to be direct targets of Notch, there are however differences in the way both genes are regulated. XNAP kinetic of induction by inducible forms of ICD and Su(H)Ank differs from that of ESR1. In cycloheximide treated caps, the ESR1 transcript level but not that of XNAP increases. The significance of these differences is unclear.
As we observed that the ability of ICD to activate XNAP expression varies in different contexts (e.g. neuralized versus non neuralized caps), it is likely that it is also influenced by other factors. Positive bHLH factors which play a critical role in neurogenesis and mesoderm segmentation are obvious candidates. Our results indicate that Xash3 and X-NGNR-1 can induce ectopic expression of XNAP, and that the upregulation of XNAP and ESR1 by X-NGNR-1 is only partially inhibited by a dominant negative version of Su(H), Su(H)DBM. Thus, we believe that part of the enhancement of XNAP and ESR1 expression is likely to occur independently of Notch activation. In Drosophila, a number of E(spl) genes are known to be direct targets of transcriptional activation both by the Notch signal dependent activator Su(H) and by the proneural bHLH proteins achaete and scute (Neellesen et al., 1999; Lai et al., 2000) . It will be interesting to determine whether the 5 0 regulatory regions of the XNAP gene also contains high affinity binding sites for proneural proteins and Su(H) and whether these binding sites are indeed essential for the regulation of XNAPexpression.
Overexpression of XNAP promotes neurogenesis by inhibiting Notch signaling
In Xenopus embryos, XNAP overexpression increases the a Embryos with X-gal staining in the neural plate were scored by comparing the number and intensity of the N-tubulin staining on the injected and uninjected sides. For each injected RNA, the total number of embryos examined is derived from three independent experiments. number of primary neurons in the domain of the neural plate where they normally form and decreases the early expression of the ESR1 and ESR10 genes, two downstream effectors of Notch signaling capable of repressing neurogenesis in overexpression experiments. In transfection assays, XNAP inhibit Notch-dependent activation of the HRT1/ Hey-1 promoter. Together, our data support the hypothesis that the increase in the number of primary neurons observed in XNAP injected embryos is due to inhibition of ESR1, ESR10 or other Notch effector genes and that XNAP functions as a feedback negative regulator of Notch signaling. These results reinforce the idea that assigning genes to synexpression groups allows to make very strong functional predictions with regards to the molecular pathway in which the genes are involved . The notch signaling pathway is often used in the same lineage to control multiple cell fate decision and its activity has therefore to change very quickly. One attracting hypothesis is that XNAP, which shows some delayed kinetic of induction compared to other Notch targets such as ESR1, may play a role in the temporal limitation of Notch activity.
How XNAP modulates Notch signaling remains to be determined. The fact that XNAP in Hela cells is able to inhibit the activation of Notch target genes by ICD suggests that XNAP is acting on downstream events of Notch signaling involving the association of ICD with Su(H) and activation of target genes. Although not observed in transfection assays, the fact that the truncated protein XNAP ank containing only the two ankyrin repeats decreases in embryos the formation of primary neurons and thus behaves as a dominant negative mutant, supports the idea that XNAP interacts with other proteins and that different regions of the proteins might be involved in these interactions. One possible way XNAP may negatively regulate Notch signaling is by interfering with ICD, Su(H) and/or any of the proteins that positively affect intracellularly the effectiveness of Notch signal transduction. Among them is the cytoplasmic Deltex protein, which appears to regulate Notch activity by antagonizing the interaction between Notch and Su(H) and preventing its cytoplamic retention (Diederich et al., 1994; Matsuno et al., 1995) . Interestingly, the expression of the Deltex gene is also activated by Notch in thymocytes (Deftos et al., 2000) , suggesting that it may also participate in a feedback regulation of Notch activity. The Su(H)-associated SKIP protein, that also interacts with the SMRThistone deacetylase corepressors and Notch ICD and the glutamin-rich proteins lag-3/ mastermind that forms a ternary complex together with NotchICD and Su(H) that appears to be crucial for NotchICD transcriptional activation (Petcherski and Kimble, 2000; Wu et al., 2000; Zhou et al., 2000) are other possible interacting partners. Another possibility is that XNAP interacts and potentiates the binding of proteins that disrupt Notch mediated transcription. Among them are the C. elegans sel-10 and murine Itch proteins, which have been shown to participate in Notch regulation by promoting ubiquitination of Notch and targeting it for degradation (Hubbard et al., 1997; Qiu et al., 2000) . The Hairless and NUMB protein are other proteins that antagonize Notch activity, by respectively acting as a transcriptional corepressor for Su(H) (Morel et al., 2001) and by preventing the translocation of NotchICD to the nucleus (Wakamatsu et al., 1999) .
Experimental procedures

XNAP constructs
A XNAP expression construct was generated by subcloning a 550 bp HincII (418) vector (Turner and Weintraub, 1994) . The myc-tagged version of the XNAP protein was obtained by PCR amplifying the full-length XNAP open reading frame from the pBluescript-XNAP plasmid (Genbank accession number AJ009276, Gawantka et al., 1998 ) using the 5 0 specific primer GAG TCC CCG CTC GAG AGT CAG GCA GAA ATG TCC (including an in frame XhoI site underlined) and a 3 0 M13 universal primer. The resulting fragment was digested with XhoI and PvuII (971) and inserted at the XhoI and SnaBI sites of the polylinker of the pCS2MT vector (Turner and Weintraub, 1994) . The XNAP Nterm construct was prepared by digestion of the pCS2MT-XNAP vector by HindIII and EarI (636), blunting of the EarI site with T4 polymerase, and relegation into the pCS2 1 MT vector into the HindIII and StuI sites. The XNAP ank construct was constructed by PCR. A fragment encoding the ankyrin motifs was amplified starting from the pCS2MT-XNAP construct using the 5 0 specific primer GAG TCC CCG CTC GAGTCC TTT GGC CCA GAG GGC C (including an in frame XhoI site underlined) and a T3 primer. The resulting fragment was digested with XhoI and NotI and cloned into the corresponding sites of the pCS2MT vector. Numbering indicates restriction site position (Gawantka et al., 1998) .
Embryos and RNA injections
Xenopus embryos were obtained from adult frogs by hormone induced egg-laying and in vitro fertilization using standard methods (Sive et al., 2000) and staged according to Nieuwkoop and Faber (1967) . Synthesis of capped RNA was performed with a Message Machine kit (Ambion, Austin, TX) and injection was carried out as described previously (Bellefroid et al., 1996) . The templates for generating full-length and deletion mutants XNAP RNA were obtained by linearizing the vectors by NotI and transcribing them with Sp6. Templates described previously include: Noggin, Notch-ICD, XSu(H), XSu(H)DBM, XSu(H)Ank, n-LacZ, hGR/NotchICD22, hGR/X-Su(H)Ank (Wettstein et al., 1997) , X-Delta-1 stu (Chitnis et al., 1995) ; X-ngnr-1 , Xash3 (Turner and Weintraub, 1994) . For embryos assayed by in situ hybridization, 500 pg of test RNAs were injected at the two-cell stage, with or without synthetic n-LacZ RNA (100 pg), encoding a nuclear-localized form of b-galactosidase. For animal cap assays, each blastomeres of four cell stage embryos were injected in the animal region with the same amount of RNAs. Caps were dissected at blastula stage and cultured on Petri dishes in 1 £ MBS containing 0.1% BSA until sibling embryos reached neurula stage. To block protein synthesis, explants were cultivated in the presence of cycloheximide (CHX) at 10 ug/ml. Dexamethasone (dex) was added at 10 uM.
Cell culture and transfections
Hela cells were grown in Dulbecco's modified eagle's medium (DMEM) with 5% fetal calf serum. Transfection were performed using the FUGENE reagent (ROCHE) according to the manufacturer's instructions and cells were examined 48 h post-transfection. For the reporter assays, each transfection included 500 ng of the luciferase reporter construct, where 1.4 kb of promoter sequences of the mouse HRT1/Hey-1 gene drives luciferase expression (B. Pichon, unpublished). In each assay, equal amount of plasmids was transfected by adding pCS2 1 MT vector. Luciferase activity was determined using the luciferase reporter gene assay (Roche). All transfections were performed in triplicate and repeated at least twice.
Immunolocalization
Embryos were fixed in MEMFA as above. Before wholemount immunolocalization, the embryos were depigmented in 1% H 2 0 2 , 5% formamide, 0.5 £ SSC under fluorescent light and stored in 100% ethanol. Mouse 9E10 anti-myc monoclonal antibody (Santa Cruz, Inc) was used at 1/400. Preincubations, secondary antibodies, washes and peroxydase reactions were as described (Perron et al., 1997) . Hela cells were fixed in 4% formaldehyde for 15 min and permeabilized in 100% methanol for 2 min. Fluorochrome-coupled secondary antibodies (Sigma D-9292) were used at 1/200. During the secondary antibody incubation, cells were stained with Hoechst (0,0005%). Images were taken with an Axioskop 2 microscope and collected with a Sony 3CCD camera (DXC-9100P).
RNAase protection assay
RNA was prepared with the phenol/NETS method and analyzed by RPA using 32 P-labeled antisense probes as previously described (Krieg, 1991) . RNAase protection probe for XNAP was generated by linearizing pBluescript-XNAP by PvuII and transcribing it with T7. The protected fragment is 249 bases long. A 187 bp ESR1 probe was obtained by linearizing a pSP72-ESR1 plasmid (Wettstein et al., 1997) by XmnI and transcribing it with Sp6. EF1-a (Wettstein et al., 1997) or rFGFantisense probes (Ryan et al., 1998) were used as loading controls. Quantification of RPA results was carried out on a Instant imager (Packard). Protected band intensities were normalized to the amount of rFGF RNA.
Whole-mount in situ hybridization and X-gal staining
Whole-mount in situ hybridizations were performed as described using digoxygenin-labeled antisense RNA probes (Sive et al., 2000) . The XNAP probe was generated by cutting pBluescript-XNAP by SalI and transcribed with T7. The other antisense RNA probes used are derived from the X-Delta-1, N-tubulin (Chitnis et al., 1995) , ESR1 (Wettstein et al., 1997) , ESR9, ESR10 (Gawantka et al., 1998) , X-MyT1 (Bellefroid et al., 1996) and Xaml-1 (Tracey et al., 1998) clones described previously. X-gal staining was performed as described (Sive et al., 2000) . For histology, whole-mount embryos were embedded in paraplast. Histological sections were dewaxed in toluene, rehydrated in PBS and mounted.
